Sagar Joshi1, Joel H Rubenstein2,3, Evan S Dellon4, Nathan Worthing5, Zoe Stefanadis6, Joy W Chang3. 1. Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. 2. Veterans Affairs Center for Clinical Management Research, Ann Arbor VA Medical Center, Ann Arbor, Michigan, USA. 3. Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. 4. Division of Gastroenterology, Center for Esophageal and Swallowing Disorders, University of North Carolina, Chapel Hill, North Carolina, USA. 5. Clark Professional Pharmacy, Ann Arbor, Michigan, USA. 6. Chapel Hill Compounding Pharmacy, Chapel Hill, North Carolina, USA.
Abstract
INTRODUCTION: Little is known about the use of compounded steroids for eosinophilic esophagitis (EoE). METHODS: We conducted a telephone survey of all compounding pharmacies in Michigan and queried about practices and costs of compounded budesonide for EoE. RESULTS: Of 68 Michigan pharmacies, 93% responded, and 20 (29%) offer compounded budesonide suspension for EoE. Formulations, dose, and instructions for use varied across pharmacies. The mean cost for a 30-day supply was $74.50. DISCUSSION: Although few compounding pharmacies offer budesonide suspension and there are substantial variations in formulations, this may be a significantly more affordable treatment option for many.
INTRODUCTION: Little is known about the use of compounded steroids for eosinophilic esophagitis (EoE). METHODS: We conducted a telephone survey of all compounding pharmacies in Michigan and queried about practices and costs of compounded budesonide for EoE. RESULTS: Of 68 Michigan pharmacies, 93% responded, and 20 (29%) offer compounded budesonide suspension for EoE. Formulations, dose, and instructions for use varied across pharmacies. The mean cost for a 30-day supply was $74.50. DISCUSSION: Although few compounding pharmacies offer budesonide suspension and there are substantial variations in formulations, this may be a significantly more affordable treatment option for many.
Authors: Jody N Hefner; Robin S Howard; Robert Massey; Miland Valencia; Derek J Stocker; Katherine Q Philla; Matthew D Goldman; Cade M Nylund; Steve B Min Journal: Dig Dis Sci Date: 2016-02-26 Impact factor: 3.199
Authors: Vincent Mukkada; Gary W Falk; Christian S Eichinger; Denise King; Lora Todorova; Nicholas J Shaheen Journal: Clin Gastroenterol Hepatol Date: 2017-06-24 Impact factor: 11.382
Authors: Cary C Cotton; Daniel Erim; Swathi Eluri; Sarah H Palmer; Daniel J Green; W Asher Wolf; Thomas M Runge; Stephanie Wheeler; Nicholas J Shaheen; Evan S Dellon Journal: Clin Gastroenterol Hepatol Date: 2016-12-07 Impact factor: 11.382
Authors: Ikuo Hirano; Edmond S Chan; Matthew A Rank; Rajiv N Sharaf; Neil H Stollman; David R Stukus; Kenneth Wang; Matthew Greenhawt; Yngve T Falck-Ytter Journal: Gastroenterology Date: 2020-05 Impact factor: 33.883